Bright Minds Biosciences Inc.DRUGNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank83
3Y CAGR-3.1%
5Y CAGR+99.0%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
-3.1%/yr
Annual compound
5Y CAGR
+99.0%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
31.2x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$11.08M+839.4%
2024$1.18M-76.4%
2023$5.00M-59.0%
2022$12.18M+92.9%
2021$6.31M+1679.3%
2020$354852.00+181.6%
2019$126027.00-